Driving Aviva's digital transformation

Chris Wei says Aviva's new digital insurance JV is a business rethink, selling no-commission term life and critical illness plans.

Genevieve Cua

Genevieve Cua

Published Tue, Oct 9, 2018 · 09:50 PM

    Singapore

    AN OPPORTUNITY to drive a UK-based insurance group's digital ambitions has turned into a passion for Chris Wei, Aviva Digital's global chairman. For Aviva, the digital challenge is bearing fruit to date. The insurer generated £1 billion (S$1.8 billion) from digital sales in the UK in 2017.

    The next challenge may well be Asia. Blue, Aviva's digital insurance joint venture with Hillhouse Capital and Tencent Holdings Ltd, has just been launched in Hong Kong, and will sell no-commission term life and critical illness plans. Direct and digital sales currently account for less than 1 per cent of Hong Kong's life insurance sales.

    Says Mr Wei: "I lucked into (digital). Mark (Wilson, until earlier this month Aviva group chief executive officer) extended me the opportunity to run this. "I told him, 'You're taking me from the biggest business of Aviva - CEO of global life insurance - to the smallest.' He said: 'You may look at it that way, or you may see it as we're having you drive the future of the business.' He is a very good salesman - he convinced me.''

    He adds: "It has led to some exciting initiatives. We have a partnership with Tencent in Hong Kong, multiple initiatives in UK, and we're looking to do more in Europe. It requires a fundamental rethink of how we do business. That's the exciting part. It's a tough journey and requires a lot of change management.''

    In the UK, the digital strategy extends to all product lines, although the majority is for general insurance products such as motor insurance.

    Capital investment in the digital strategy cost £100 million at the start. "We said we'd have £100 million of ring-fenced money, but we don't count anymore because it's way past that. It's now in multiples of that. You can't just look at digital on its own. It is integrated with the rest of our architecture, and has to be seen in the context of Aviva digitising everything.'' The group employs roughly 600 data scientists.

    Mr Wei initially joined the group in 2014 as chief executive of global life business and Asia chairman. In just about a year, he was appointed global chairman for Aviva Digital, a newly created post, and executive chairman for Aviva Asia. He was formerly group chief executive of Great Eastern Holdings. In Singapore, the focus of digitisation is more on the B2B rather than B2C business. "Because of our strategy, it's less direct-to-consumer digital. It's more about digitising our advisers and the customer claims experience.''

    As one of the biggest providers of group health insurance, for instance, the group has taken steps to ease the claims process. "People can log onto the Aviva app and submit digital claims. That's delivering better customer experience.''

    It has also digitised another distribution channel, the financial advisers' (FA) business. "Where we have grown nicely is the FA business. FAs can directly input into a modern system which dovetails into our underwriting engine, which can have more than 80 per cent straight-through-processing. They can get underwriting decisions immediately. All of that streamlines the business.''

    On Blue, the Hong Kong joint venture, he said: "We'll have the most economical product in the market and the simplest. People don't wake up thinking: 'Let's go buy insurance.' We need marketing and engagement innovation - that's what we'll be testing.

    "We're trying a different model. Can we change the paradigm that insurance is bought, not sold? We have to raise awareness, engage the customer, which requires a lot of marketing technology.''

    Aviva has been investing in other tech ventures. One is Biofourmis, a Singapore-based digital healthtech company, which raised US$5 million in Series A financing from NSI Ventures and Aviva Ventures late last year.

    Biofourmis has developed a health analytics platform called biovitals, which uses artificial intelligence to integrate and analyse physiology data from clinical-grade wearables, and to detect patterns that can predict a patient's health deterioration. Aviva is understood to be in discussion with the firm on utilising the platform in Singapore for better healthcare management for Aviva customers.

    Aviva Ventures has also invested in Swingvy, a human resource platform that aims to transform HR practice for small and medium-sized businesses. The firm connects and automates HR, payroll and employee benefits in one platform.

    Aviva Ventures is the corporate venture capital fund of Aviva plc, which aims to invest £100 million in early stage businesses by 2020.